Lipotek  - logo

Lipotek - Company & Market Research Reports

Lipotek Pharmaceutical is based in Australia and It was founded in 2001. The offices and laboratories for this company are located on the grounds of the Australian National University campus. The company's aim is to gain ‘proof of concept’ for their Lipovaxin and Lipokel adjuvant platforms with the aim to gain strategic alliances with biotech and pharmaceutical companies. Lipotek operates primarily as a Research and Development company seeking to commercialise and create adjuvant and delivery technologies to improve vaccine formulations. In recent years this company has focused on particular diseases such as: cancer, malaria and tuberculosis.


Advanced and Targeted Drug Delivery Market Segmentation, Analysis & Forecast to 2021 - Product Thumbnail Image

Advanced and Targeted Drug Delivery Market Segmentation, Analysis & Forecast to 2021

  • Report
  • 382 Pages
From
Antibacterial Therapies Drug Development Pipeline Review, 2017 - Product Thumbnail Image

Antibacterial Therapies Drug Development Pipeline Review, 2017

  • Report
  • 418 Pages
From
Mycobacterium tuberculosis ESAT 6 Protein EsxA (6 kDa Early Secretory Antigenic Target or esxA) - Pipeline Review, H2 2016 - Product Thumbnail Image

Mycobacterium tuberculosis ESAT 6 Protein EsxA (6 kDa Early Secretory Antigenic Target or esxA) - Pipeline Review, H2 2016

  • Report
  • 38 Pages
From
Lipotek Pty Ltd. - Product Pipeline Review - 2015 - Product Thumbnail Image

Lipotek Pty Ltd. - Product Pipeline Review - 2015

  • Company Profile
  • 20 Pages
From
Melanoma - Pipeline Review, H2 2017 - Product Thumbnail Image

Melanoma - Pipeline Review, H2 2017

  • Report
  • 1876 Pages
From
Melanoma - Pipeline Review, H1 2017 - Product Thumbnail Image

Melanoma - Pipeline Review, H1 2017

  • Report
  • 1779 Pages
From
Metastatic Melanoma - Pipeline Review, H2 2016 - Product Thumbnail Image

Metastatic Melanoma - Pipeline Review, H2 2016

  • Report
  • 648 Pages
From
Metastatic Melanoma - Pipeline Review, H1 2016 - Product Thumbnail Image

Metastatic Melanoma - Pipeline Review, H1 2016

  • Report
  • 675 Pages
From
Metastatic Melanoma - Pipeline Review, H2 2015 - Product Thumbnail Image

Metastatic Melanoma - Pipeline Review, H2 2015

  • Report
  • 623 Pages
From
Metastatic Melanoma - Pipeline Review, H1 2015 - Product Thumbnail Image

Metastatic Melanoma - Pipeline Review, H1 2015

  • Report
  • 502 Pages
From
Biotherapeutics: Novel Formulation and Delivery Approaches (Focus on Antibodies and Proteins) - Product Thumbnail Image

Biotherapeutics: Novel Formulation and Delivery Approaches (Focus on Antibodies and Proteins)

  • Report
  • 301 Pages
From
Dendrimers and Polymer Drug Conjugates Market, 2016 - 2026 - Product Thumbnail Image

Dendrimers and Polymer Drug Conjugates Market, 2016 - 2026

  • Report
  • 183 Pages
From
  • 12 Results (Page 1 of 1)
Loading Indicator
adroll